RxDoctor Payments Data

Susan Stine, MD

Psychiatry · Detroit, MINPI 1881631372

Payments from drug & device makers

$698in general payments, 2019–2025

Across 31 payments — averaging $22.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$244
  • Johnson & Johnson$107
  • AbbVie$92
  • Alkermes, Inc.$75
  • Axsome Therapeutics, Inc.$44
  • Teva Pharmaceuticals USA, Inc.$41
  • plus $94 from 4 others

What the payments were for

  • Food & beverage$66896%
  • Education$304%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$698 in reported general payments places this provider in the 70th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$24,736
Medicare patients
69
Services billed
196

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
NuedextaDextromethorphan Hbr/Quinidine18$27,778
Paliperidone ErPaliperidone81$18,719
Divalproex Sodium ErDivalproex Sodium217$11,123
Quetiapine Fumarate307$5,907
Clozapine50$5,610
Risperidone418$5,406
Aripiprazole234$4,813
Trazodone Hcl327$4,455
Fluvoxamine Maleate ErFluvoxamine Maleate12$3,724
Fluoxetine Hcl247$3,211
Ziprasidone Hcl59$3,147
Olanzapine193$3,084
Clomipramine Hcl36$2,910
Fluvoxamine Maleate34$2,780
Lorazepam225$2,746

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Avanir Pharmaceuticals, Inc.Nuedexta$14$27,77818 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →